glp 1 drugs moa GLP1 Receptor Agonists—Effects beyond Obesity and Diabetes GLP-1 receptor agonists in the

The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest Statements Conflict of interest Within the last 36 months, FK has served on scientific advisory panels and/or been part of speaker's bureaus for, served as a consultant to and/or received research support from Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Gubra, MedImmune, MSD/Merck, Mundipharma, Norgine, Novo Nordisk, Sanofi and Zealand Pharma

The 12-month gap was identified as part of an empirical correlation analysis between discontinuation time as apparent within specialist records (hospital data) vs

You can cancel at anytime

Avoid injecting into areas that are tender, bruised, red, or hardened , and do not use areas with scars or stretch marks

Much like statins have become a drug you take long-term to manage your cholesterol, a GLP-1 pill might become something you take for years to manage your weight